Management of chronic hepatitis B in pregnancy

World Journal of Gastroenterology

Volumn 18, Issue 33, 2012, Pages 4517-4521

  Han, Guo Rong ^a   Xu, Chuan Lu ^a   Zhao, Wei ^a   Yang, Yong Feng ^a  

^a Nanjing Second Hospital   (China)

Author keywords

Antiviral therapy; Chronic hepatitis B; Hepatitis B virus; Mother to child transmission; Perinatal transmission; Pregnancy; Vertical transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TELBIVUDINE; TENOFOVIR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BREAST FEEDING; CELL PROLIFERATION; CORRELATION ANALYSIS; DELIVERY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG EFFICACY; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PREGNANCY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; LIVER FAILURE; LIVER FIBROSIS; LIVER METABOLISM; MATERNAL AGE; NEWBORN PERIOD; PATIENT MONITORING; PERINATAL PERIOD; PREGNANCY; PREGNANCY DIABETES MELLITUS; SCREENING TEST; SEROCONVERSION; THERAPY EFFECT; VERTICAL TRANSMISSION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 84867735342     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i33.4517     Document Type: Article

References (59)

1. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003; 39 Suppl 1: S64-S69
2. Gambarin-Gelwan M. Hepatitis B in pregnancy. Clin Liver Dis 2007; 11: 945-963, x
3. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003; 362: 2089-2094
4. Lok AS. Chronic hepatitis B. N Engl J Med 2002; 346: 1682-1683
5. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550-6557
6. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135: 796-800
7. Zhang L, Xu A, Yan B, Song L, Li M, Xiao Z, Xu Q, Li L. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination. Int J Infect Dis 2010; 14: e483-e488
8. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009; 29 Suppl 1: 133-139
9. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and metaanalysis. BMJ 2006; 332: 328-336
10. Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010; 53: 20-28
11. Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res 2010; 40: 31-48
12. Kwon CI, Hwang SG, Shin SJ, Chang SW, Kim SY, Ko KH, Hong SP, Park PW, Rim KS, Kang MS, Chung HJ, Hong SP. Occult hepatitis B virus infection in pregnant woman and its clinical implication. Liver Int 2008; 28: 667-674
13. Alexiou VG, Ierodiakonou V, Peppas G, Falagas ME. Antimicrobial prophylaxis in surgery: an international survey. Surg Infect (Larchmt) 2010; 11: 343-348
14. Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS. Analyses of prognostic indices of chronic liver failure caused by hepatitis virus. World J Gastroenterol 2005; 11: 2841-2843
15. Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008; 48: 1577-1585
16. Hieber JP, Dalton D, Shorey J, Combes B. Hepatitis and pregnancy. J Pediatr 1977; 91: 545-549
17. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10: 61-69
18. Reinus JF, Leikin EL. Viral hepatitis in pregnancy. Clin Liver Dis 1999; 3: 115-130
19. Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009; 49: S156-S165
20. Wong HY, Tan JY, Lim CC. Abnormal liver function tests in the symptomatic pregnant patient: the local experience in Singapore. Ann Acad Med Singapore 2004; 33: 204-208
21. Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005; 43: 771-775
22. ter Borg MJ, Leemans WF, de Man RA, Janssen HL. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat 2008; 15: 37-41
23. Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL. Treatment of chronic hepatitis B virus infection-Dutch national guidelines. Neth J Med 2008; 66: 292-306
24. Söderström A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35: 814-819
25. Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003; 71: 360-366
26. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998; 27: 100-106
27. Sangfelt P, Reichard O, Lidman K, von Sydow M, Forsgren M. Prevention of hepatitis B by immunization of the newborn infant--a long-term follow-up study in Stockholm, Sweden. Scand J Infect Dis 1995; 27: 3-7
28. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 1999; 6: 135-139
29. Lin HH, Chen PJ, Chen DS, Sung JL, Yang KH, Young YC, Liou YS, Chen YP, Lee TY. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers. J Med Virol 1989; 29: 1-6
30. Lin HH, Wu WY, Kao JH, Chen DS. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: Correlation with viral characteristics. J Gastroenterol Hepatol 2006; 21: 605-609
31. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang ZL, Ng HT. Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988; 2: 833-834
32. Yang J, Zeng XM, Men YL, Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus--a systematic review. Virol J 2008; 5: 100
33. Tran TT. Management of hepatitis B in pregnancy: weighing the options. Cleve Clin J Med 2009; 76 Suppl 3: S25-S29
34. Ahn J, Salem SB, Cohen SM. Evaluation and management of hepatitis B in pregnancy: a survey of current practices. Gastroenterol Hepatol (N Y) 2010; 6: 570-578
35. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007; 166: 813-818
36. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, de Gast GC, Fetter WP, Zwijneberg J, Schalm SW. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15: 1624-1630
37. Lin HH, Chang MH, Chen DS, Sung JL, Hong KH, Young YC, Yang KH, Lee TY. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991; 9: 457-460
38. Boot HJ, Hahné S, Cremer J, Wong A, Boland G, van Loon AM. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination. J Viral Hepat 2010; 17: 872-878
39. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA, Levy MT. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190: 489-492
40. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20-26
41. Shin JI, Namgung R, Park MS, Park KI, Lee C. Immunoprophylaxis failure against vertical transmission of hepatitis B virus: what is the mechanism and do other factors also play a role? Eur J Pediatr 2008; 167: 489-490
42. Singh AE, Plitt SS, Osiowy C, Surynicz K, Kouadjo E, Preiksaitis J, Lee B. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011; 18: 468-473
43. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170: 1418-1423
44. del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink RA. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994; 20: 483-486
45. Abstracts of the 59th Annual Meeting of the American Association for the Study of Liver Diseases, 2008. October 31-November 4, 2008. San Francisco, California, USA. Hepatology 2008; 48 Suppl 1: 309A-1187A
46. Buchanan C, Tran TT. Management of chronic hepatitis B in pregnancy. Clin Liver Dis 2010; 14: 495-504
47. Chen LZ, Zhou WQ, Zhao SS, Liu ZY, Wen SW. A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population. World J Gastroenterol 2011; 17: 3640-3644
48. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX. A prospective and openlabel study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011; 55: 1215-1221
49. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45: 1056-1075
50. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International interim report for 1 January 1989-31 July 2010. Antiviral Pregnancy Registry, July 2010. Available from: URL: http: //www. apregistry.com/forms/interim_report.pdf
51. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10: 294-297
52. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94-103
53. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-242
54. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662
55. Chotiyaputta W, Lok AS. Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat 2009; 16: 91-93
56. Boland GJ, Veldhuijzen IK, Janssen HL, van der Eijk AA, Wouters MG, Boot HJ. [Management and treatment of pregnant women with hepatitis B]. Ned Tijdschr Geneeskd 2009; 153: A905
57. Petersen J. HBV treatment and pregnancy. J Hepatol 2011; 55: 1171-1173
58. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999; 341: 1256-1263
59. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54: 1-31